Showing results (701-710 of 9,900) with videos related to
Sort By:
Pageof 990
Bone Marrow Transplantation|November 18, 2022
New trends in the management of cytomegalovirus infection after allogeneic hematopoietic cell transplantation: a survey of the Infectious Diseases Working Pary of EBMTSimone Cesaro, Per Ljungman, Gloria Tridello, et al.Bone Marrow Transplantation|November 14, 2022
Identifying the optimal conditioning intensity for stem cell transplantation in patients with myelodysplastic syndrome: a machine learning analysisYoshimitsu Shimomura, Sho Komukai, Tetsuhisa Kitamura, et al.Bone Marrow Transplantation|July 22, 1999
Beta2-microglobulin and bone marrow plasma cell involvement predict complete responders among patients undergoing blood cell transplantation for myelomaS V Rajkumar, R Fonseca, M Q Lacy, et al.Bone Marrow Transplantation|July 22, 1999
Peripheral blood stem cell transplantation as an alternative to autologous marrow transplantation in the treatment of acute myeloid leukemia?E Vellenga, W L van Putten, M A Boogaerts, et al.Bone Marrow Transplantation|July 22, 1999
A metalloproteinase inhibitor prevents acute graft-versus-host disease in mice after bone marrow transplantationK Hattori, T Hirano, C Ushiyama, et al.Bone Marrow Transplantation|May 21, 1999
Management strategies for the hard-to-mobilize patientP J StiffBone Marrow Transplantation|June 18, 1999
Incidence and outcome of Clostridium difficile infection following autologous peripheral blood stem cell transplantationS Bilgrami, J M Feingold, D Dorsky, et al.Bone Marrow Transplantation|June 18, 1999
Nutritional status and growth after bone marrow transplantation (BMT) during childhood: EBMT Late-Effects Working Party retrospective data. European Group for Blood and Marrow TransplantationA Cohen, T Duell, G Socié, et al.Bone Marrow Transplantation|August 6, 1999
Role of interleukin-12 in the development of acute graft-versus-host disease in bone marrow transplant patientsM Yabe, H Yabe, K Hattori, et al.Bone Marrow Transplantation|August 6, 1999
Gut mucosa barrier preservation by orally administered IgA-IgG to patients undergoing bone marrow transplantation: a randomised pilot studyJ E Johansson, T EkmanPageof 990